2020
DOI: 10.20546/ijcmas.2020.906.406
|View full text |Cite
|
Sign up to set email alerts
|

Pandemic of Infectious Diseases due to New Etiological Agents Predisposing Factors, Case study of COVID19 and Control Measures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 122 publications
0
1
0
Order By: Relevance
“…SB offers potential benefits for immunoassay development, diagnosis, drug screening, new antibiotics generation, drug production and sensor-effector therapeutic development [ 3 3 ] . D i a g n o s i s o f c o m m u n i c a b l e a n d non-communicable diseases including cancer, coronary artery disease, ebola, Zika, tuberculosis, malaria, HIV, SARS-coV-2, routine blood test quantification, and water quality monitoring has been successfully performed using SB [32,34]. Recent work in animal models for human diseases has shown that the use of sensor effectors and mammalian cell reprogramming may soon pave the way for genetic and cellular therapies [35].…”
Section: Health Applicationsmentioning
confidence: 99%
“…SB offers potential benefits for immunoassay development, diagnosis, drug screening, new antibiotics generation, drug production and sensor-effector therapeutic development [ 3 3 ] . D i a g n o s i s o f c o m m u n i c a b l e a n d non-communicable diseases including cancer, coronary artery disease, ebola, Zika, tuberculosis, malaria, HIV, SARS-coV-2, routine blood test quantification, and water quality monitoring has been successfully performed using SB [32,34]. Recent work in animal models for human diseases has shown that the use of sensor effectors and mammalian cell reprogramming may soon pave the way for genetic and cellular therapies [35].…”
Section: Health Applicationsmentioning
confidence: 99%